Movatterモバイル変換


[0]ホーム

URL:


Journal Logo

Email to Colleague

Colleague's E-mail is Invalid

Your Name:
Colleague's Email:
Separate multiple e-mails with a (;).
Message:

Your message has been successfully sent to your colleague.



Some error has occurred while processing your request. Please try after some time.

Export to

Brief Report

Catatonia After Benzodiazepine Withdrawal

Rosebush, Patricia I. MScN, MD, FRCP(C); Mazurek, Michael F. MD, FRCP(C)

Author Information

Departments of (Rosebush, Mazurek) Psychiatry, (Mazurek) Medicine (Neurology), and (Rosebush, Mazurek) Biomedical Sciences, (Neuroscience), McMaster University, Hamilton, Ontario.

Received June 6, 1995; accepted after revision December 15, 1995.

Address requests for reprints to: Dr. P.I. Rosebush, Department of Psychiatry, McMaster University Medical Centre, 1200 Main Street West, Hamilton, Ontario, Canada, L8N 3Z5.

Journal of Clinical Psychopharmacology16(4):p 315-319, August 1996.

Abstract

The use of benzodiazepine medication is associated with a variety of acute and well-recognized withdrawal syndromes including anxiety, agitation, insomnia, and confusion. Catatonia has not previously been described. We report five patients who became catatonic after withdrawal of benzodiazepines. All five were older individuals (53-88 years) who had acutely become immobile, mute, and rigid with refusal or inability to eat or drink. Each of the five showed pronounced and rapid improvement after administration of low-dose lorazepam, which has previously been reported to be effective in the treatment of catatonia. Careful review of the records showed that each of the patients had been taking benzodiazepine medication for anywhere from 6 months to 15 years and that it had been rapidly tapered or abruptly discontinued 2 to 7 days before the onset of catatonia. These cases illustrate that severe and potentially life-threatening catatonia can develop in the wake of benzodiazepine withdrawal. Older individuals may be particularly vulnerable to this side effect. (J Clin Psychopharmacol 1996;16:315-319).

© Williams & Wilkins 1996. All Rights Reserved.

You can read the full text of this article if you:

Log InAccess through Ovid

Source

Journal of Clinical Psychopharmacology16(4):315-319, August 1996.
Email to Colleague

Colleague's E-mail is Invalid

Your Name:
Colleague's Email:
Separate multiple e-mails with a (;).
Message:

Your message has been successfully sent to your colleague.



Some error has occurred while processing your request. Please try after some time.


[8]ページ先頭

©2009-2025 Movatter.jp